US-based Natus Medical Incorporated, the world's largest pure-play neurodiagnostic company, recently celebrated the grand opening of its development and manufacturing facility in Suzhou.
This opening marks an important step in the company's long-term commitment to China, bringing global neurodiagnostic expertise together with local talent and manufacturing capabilities to better serve clinicians and patients in China.
The celebration builds on the September launch of the locally manufactured Nicolet EDX EMG system, the first Natus product manufactured and sold in the People's Republic of China. Built at the Suzhou site, Nicolet EDX became the first locally manufactured Natus product registered in China after receiving final approval from the National Medical Products Administration (NMPA) on June 18.
The Suzhou facility strengthens collaboration across development, production, quality, and technical support teams. By combining the global technology of Natus and experience with local insight and capabilities, the site supports the company's ability to respond to the needs of healthcare institutions across China, where healthcare procurement increasingly prioritises locally manufactured medical technologies.
Nicolet EDX is an electrodiagnostic system from Natus that supports nerve conduction studies and wide range of EMG and EP studies, helping clinicians collect and analyse electrophysiological information to support the diagnosis of neuromuscular diseases and conditions.
